- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Company clarified the utilization of 102.48 Cr from preferential warrants: 20 Cr for working capital, 17.48 Cr for general corporate needs, and 65 Cr for CAPEX. A monitoring agency will oversee fund deployment.
All announcements from Vaidya Sane Ayurved Laboratories Limited